MarginsXMarginsX
Home › Markets › Health Care › LMAT

LeMaitre Vascular Inc. (LMAT)

LMAT trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$77.01
-1.63% on the day
Market cap
$1.8B
Small cap
Revenue · 2025
$249.6M
+13.5% on 2024
Net income · 2025
$57.7M
23.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1158895/000119312526073360/0001193125-26-073360-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerLMAT on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2006
SEC CIK0001158895
SEC industry codeSurgical & Medical Instruments & Apparatus

Financials · 2025

LineValue
Revenue$249.6M
Net income$57.7M
Operating income$67.9M
Net margin23.1%
Operating margin27.2%
Revenue growth+13.5%
Cash$28.2M
Total assets$615.7M
P/E (computed)30.5×
P/S (computed)7.1×

Warning signs

Cash runway
Cash-flow positive
$27.5M cash at September 30, 2026
Share count, 1 year
+0.9%
2025-11-03 to 2026-11-02 · +2.8% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$30.0M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$27.5M cash; operating cash flow $19.1M a quarter.Report 2026-09-30
Shares outstanding22,880,871 (2026-11-02); 22,685,994 a year earlier; 22,263,235 three years earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorGrant Thornton LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-10
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $30.0M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$68.0M$15.0M$22.0M$27.5M$169.3M$269.4M10-Q 2026-11-05
Q2 2026
2026-06-30
$70.4M$17.1M$16.0M$26.6M$169.1M$262.4M10-Q 2026-08-05
Q1 2026
2026-03-31
$66.6M$15.7M$15.1M$26.9M$168.9M$256.3M10-Q 2026-05-06
Q4 2025
2025-12-31
$64.5M$15.6M$23.2M$28.2M$168.6M$249.6M10-K 2026-02-26
Q3 2025
2025-09-30
$61.0M$17.4M$28.8M$25.5M$168.4M$240.9M10-Q 2026-11-05
Q2 2025
2025-06-30
$64.2M$13.8M$20.3M$27.2M$168.2M$234.6M10-Q 2026-08-05
Q1 2025
2025-03-31
$59.9M$11.0M$9.0M$25.3M$168.0M$226.3M10-Q 2026-05-06
Q4 2024
2024-12-31
$55.7M$11.2M$15.2M$25.6M$167.8M$219.9M10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B5
424B52021-07-15
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-14

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-3.2%
1 month-4.0%
3 months-4.4%
Year to date-3.5%
1 year-12.7%
From 52-week high-33.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
XRAYDENTSPLY SIRONA Inc.$8.95-2.35%$1.8B
INSPInspire Medical Systems Inc.$59.12-3.24%$1.7B
KMTSKestra Medical Technologies Ltd.$27.97-2.34%$1.7B
PRCTPROCEPT BioRobotics Corporation$23.54-1.09%$1.4B
UFPTUFP Technologies Inc.$298.54-2.14%$2.3B
NVCRNovoCure Limited$11.30-4.48%$1.3B
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B
DRTSAlpha Tau Medical Ltd.$11.97-10.54%$1.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier